Repare Therapeutics scores $68 mln Series A
Montreal and Boston-based Repare Therapeutics, a developer of drugs that treat cancer, has raised $68 million in Series A financing. Versant Ventures and MPM Capital led the round with participation from other investors that included Fonds de solidarité FTQ, Celgene Switzerland and BDC Capital.
22 June 2017•1 min read
